AMGEN INC (AMGN) Deferred Income Tax Expense (Benefit) USD 2015 - 2018
Historical data
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Amgen Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from 2015 to 2018.
- Amgen Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2018 was -$72 M, a 6.49% increase year-over-year.
- Amgen Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$1.22 B, a 4.71% increase from 2022.
- Amgen Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.28 B, a 194% decline from 2021.
- Amgen Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$434 M, a 19.6% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)